1,5-Bis(4-allyldimethylammoniumphenyl)pentan-3-one, dibromide
CAS: 402-40-4
Ref. 3D-FB18689
2mg | 136,00 € | ||
5mg | 138,00 € | ||
10mg | 194,00 € | ||
25mg | 310,00 € | ||
50mg | 436,00 € |
Información del producto
- 4,4'-(3-Oxo-1,5-pentanediyl)bis[N,N-dimethyl-N-2-propen-1-yl-benzenaminium bromide
- 1,5-Bis(p-N-allylmethylaminophenyl)-pentan-3-one dimethylbromide
- 1,5-Bis-(4-allyldimethylammoniumphenyl)-pentane-3-one dibromide
- 1,5-Bis[4-(allyldimethylammonium)phenyl]pentan-3-one dibromide
- 4,4'-(3-oxopentane-1,5-diyl)bis[N,N-dimethyl-N-(prop-2-en-1-yl)anilinium] dibromide
- Ammonium, [(3-oxopentamethylene)di-p-phenylene]bis[allyldimethyl-, dibromide
- Benzenaminium, 4,4′-(3-oxo-1,5-pentanediyl)bis[N,N-dimethyl-N-2-propen-1-yl-, bromide (1:2)
- Benzenaminium, 4,4′-(3-oxo-1,5-pentanediyl)bis[N,N-dimethyl-N-2-propenyl-, dibromide
- Bw 284
- Bw 284C51
- Ver más sinónimos
- [(3-Oxopentamethylene)di-p-phenylene]bis[allyldimethylammonium bromide]
1,5-Bis(4-allyldimethylammoniumphenyl)pentan-3-one, dibromide is a reversible inhibitor of acetylcholinesterase. It has been shown to inhibit the enzyme activity in vitro and in vivo. 1,5-Bis(4-allyldimethylammoniumphenyl)pentan-3-one, dibromide has been shown to be an effective inhibitor of nicotinic acetylcholine receptors in model organisms such as Xenopus oocytes and Acetylcholine esterase activated rat pheochromocytoma cells. The molecule also inhibits the phosphorylation of pnitrophenyl phosphate by choline kinase. This inhibiting effect on choline kinase leads to a decrease in the concentration of choline available for neurotransmitter synthesis. Monoclonal antibodies against acetylcholinesterase are used to detect this
Propiedades químicas
Consulta técnica sobre: 3D-FB18689 1,5-Bis(4-allyldimethylammoniumphenyl)pentan-3-one, dibromide
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.